CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.
March 29th 2021
Although “social distancing” has become a common term used to describe the safe distance people keep from others to avoid contracting COVID-19, stage 1 ovarian cancer survivor and teacher Brenda Kowalski reminds patients who may be starting out on their cancer journey that it’s important to not “socially distance” yourself from friends when you need support.
March 23rd 2021
The phase 3 ARIEL4 trial evaluated Rubraca (rucaparib) versus chemotherapy in patients with ovarian cancer and a BRCA mutation who did not respond to two or more lines of chemotherapy.
March 20th 2021
Fertility treatments led to a cancer diagnosis but also opened the door to adoption and a new view on life.
March 12th 2021
Being creative has helped this ovarian cancer survivor during her journey. She recommends that people use their energy in a positive way and do something that will make a difference in their lives.
March 12th 2021
From a Louisiana-based motorcycle club holding a 57-mile ride to raise money for a fellow member with ovarian cancer to the World Health Organization (WHO) announcing an initiative to reduce global breast cancer mortality by 2.5 million by 2040, here’s what’s happening in the cancer space this week.
March 4th 2021
An ovarian cancer survivor shares that although she’s been frustrated and mad about a recent recurrence in her lymph nodes, she still celebrates the life that she’s been blessed with.
March 1st 2021
Although a gynecologic oncologist has spent a good part of her career helping patients during their cancer journeys, she took it upon herself to take one step further to educate women on how they can advocate for themselves and potentially prevent cancer before it impacts their lives.
February 26th 2021
A roundup of some of the latest news and updates for patients with ovarian cancer from CURE®.
February 25th 2021
In this episode of the “CURE Talks Cancer” podcast, we spoke with a gynecologic cancer expert about how her sister’s journey with ovarian cancer provided her with a different perspective that would lead to raising awareness for others.
February 24th 2021
Two evaluations for treatment responses in women with ovarian, fallopian tube or primary peritoneal carcinoma may need to take into consideration other factors such as other existing conditions.
February 14th 2021
A cancer survivor remembers his wife who died of complications from ovarian cancer on Valentine’s Day several years ago. His advice to everyone: Holidays gradually become positive reflections of all that was good before cancer took it away.
February 8th 2021
Diane Powis spent more than 10 months bouncing from one doctor to the next before finally being “blindsided by” a diagnosis of stage 3 ovarian cancer. But as her initial feelings of isolation and fear wore off, Powis soon learned that she wasn’t alone – and that help and information were out there.
February 6th 2021
At the moment it may be hard to realize, but your life is not over because of cancer.
February 4th 2021
In this episode of the “CURE® Talks Cancer” podcast, we spoke with a patient who was blindsided by her stage 3 ovarian cancer diagnosis several years ago. We talk about how she spent months going from specialist to specialist before finally receiving her diagnosis, and why she dedicates much of her time to advocating for others.
January 22nd 2021
Women who reported using oral contraceptives had a decreased risk of endometrial and ovarian cancer, compared to those who never used the hormone medications. The data also indicated the association extended up to three decades after patients stopped using the contraceptives.
January 16th 2021
It’s okay for me to not feel like celebrating my 5-year cancerversary in a world that is upside down and backward because of COVID-19. Yes, I’m grateful and blessed, but I’m not bullet-proof. I’m human. I don’t have to feel guilty. None of us do.
January 8th 2021
In an interview with CURE®, the “Felicity” and “Scandal” actor spoke about his experience as a caregiver to his mother, and why women should not just watch and wait for their ovarian cancer to recur.
January 5th 2021
A gynecologic oncology expert from the University of California, Davis reviewed early-stage ovarian cancer and the importance of knowing what options are available before, during and after treatment.
January 4th 2021
A roundup of some ovarian cancer news and updates that occurred in 2020 that patients may have missed.
December 28th 2020
Women with ovarian cancer report a better quality of life when treated with a combination of Keytruda, Avastin and oral metronomic cyclophosphamide.
December 22nd 2020
Keytruda (pembrolizumab), Avastin (bevacizumab) and cyclophosphamide contributed to a clinical benefit in 95% of women in the trial and a durable treatment response of 12 months or longer in 25% of women.
October 17th 2020
Watch the entire Ovarian Cancer Heroes program right here!
October 17th 2020
An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.
October 6th 2020
Time is a valuable commodity, especially for patients with cancer who may find themselves with limited time or limited free time to enjoy the things they loved prior to their cancer. But the COVID-19 pandemic is robbing patients of that precious time.
September 29th 2020
Five-year follow-up data from the phase 3 SOLO-1 trial demonstrates a nearly five-year delay in disease progression with Lynparza compared with a delay of just over a year with placebo in women with newly diagnosed, advanced ovarian cancer harboring a BRCA gene mutation.
September 28th 2020
A weekly high dose of chemotherapy did not improve survival for patients with epithelial ovarian cancer, though the treatment regimen was effective and well-tolerated.
September 11th 2020
A proposed preventive surgery that would take out fallopian tubes before menopause but save ovary removal until afterwards was favored by most premenopausal previvors of ovarian cancer in a study.
September 11th 2020
The study results also showed that older age was significantly associated with lower cancer genetics knowledge, which, according to a post-doctoral research fellow at Dana-Farber Cancer Institute, is important because older adults may serve as a resource for family members who seek information about their family's health history.
September 10th 2020
Compared to physician’s choice of chemotherapy, the MEK inhibitor Mektovi failed to improve progression-free survival in patients with low-grade serous ovarian carcinomas. However, the study authors note Mektovi demonstrated promising results that support continued use of the treatment.